Search the Newsreel

Rolex Rings Q1 Results: Earnings Call Audio Made Public

Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook

Completes Sale of OEM Business and Will Deploy Net Proceeds to Reduce Debt and Repurchase Common Stock Announces $250 Million Accelerated Share Repurchase Program, Repurchased $250 Million of Common Stock in the Second Quarter WAYNE, Pa., August 06, 2026--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (the …

Chapin Davis Inc. Takes Position in Flex Ltd. $FLEX

Chapin Davis Inc. recently acquired 97,607 shares of Flex Ltd. (NASDAQ:FLEX) in the second quarter, valuing its new position at approximately $15.8 million and making it the fund's ninth-largest holding. Institutional investors own a significant 94.3% of Flex, while analyst sentiment remains largely positive …

Lexicon Pharmaceuticals, Inc. (LXRX) Stock Price, News, Quote & History

Lexicon Pharmaceuticals, Inc. (LXRX) closed at $2.3600, down 3.67%, with after-hours trading showing a further slight decrease. The company, focused on biopharmaceutical products, reported Q2 2026 earnings and has several drugs in development including sotagliflozin (INPEFA, ZYNQUISTA) and new candidates for obesity and neuropathic …

Lexeo Therapeutics (LXEO) Projected to Release Earnings on Thursday

Lexeo Therapeutics (LXEO) is expected to release its Q2 2026 earnings before market open on Thursday, August 13th, with analysts projecting a loss of $0.30 per share. The company, currently unprofitable with a market capitalization of $349 million, has a "Buy" consensus rating and …

California State Teachers Retirement System Boosts Stock Holdings in Teleflex Incorporated $TFX

Plexus Corp. $PLXS Shares Purchased by Amundi

Amundi increased its stake in Plexus Corp. ($PLXS) by 143% in the first quarter, now owning 31,294 shares valued at $6.34 million, making them one of several institutional investors to adjust their positions. Plexus reported strong quarterly results, exceeding analyst expectations with $2.32 EPS …

Teleflex: Q2 Earnings Snapshot

Teleflex (NYSE:TFX) Exceeds Q2 CY2026 Expectations

Teleflex (NYSE:TFX) Exceeds Q2 CY2026 Expectations Medical technology company Teleflex (NYSE:TFX) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 28.9% year on year to $570.3 million. Its non-GAAP profit of $1.76 per share was 37.4% above analysts' consensus estimates. …

Enerflex Shares Drop After Q2 Earnings, Revenue Fall

Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Gap Down on Disappointing Earnings

Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Lags Revenue Estimates

Lexicon Pharmaceuticals (LXRX) Earnings Date and Reports 2026 $LXRX

Enerflex (NYSE: EFXT) Q2 2026: $582M revenue, $1.5B ES backlog and lower net debt

Lexinfintech Holdings Ltd (LX) Earnings Forecast: Future EPS & Revenue Growth Estimates

Teleflex (TFX) Earnings Date and Reports 2026 $TFX

Teleflex (NYSE: TFX) lifts Q2 revenue 29% amid major divestitures

Teleflex (NYSE:TFX) Posts Quarterly Earnings Results, Beats Estimates By $0.48 EPS

Finolex Industries Q1 Results: EBITDA up 16% YoY to ₹109 Cr despite volume slide

FlexiRoam Limited (ASX:FRX) Shares Slip as Etihad Partnership Enters Focus

Are Wall Street Analysts Bullish on Flex Ltd. Stock?

Flex Ltd. (FLEX) has significantly outperformed the broader market and its industry benchmark over the past year, driven by strong demand for its AI infrastructure solutions. Following robust Q1 2026 earnings, analysts have a "Strong Buy" consensus rating for FLEX, with a mean price …

Flex Ltd. (FLEX) stock price, news, quote and history

This article provides a comprehensive overview of Flex Ltd. (FLEX) stock, including its current price, historical data, and financial performance. It details the company's business segments, analyst ratings, and compares its returns against the S&P 500. The information presented is current as of August …

Flex LNG’s Aug. 19 Results Include a Live Video Q&A

Flex LNG (FLNG) is scheduled to release its unaudited financial results for the second quarter of 2026 on Wednesday, August 19, 2026, at 07:00 CEST (1:00 a.m. EST). The company will host a live video webcast of its earnings presentation on the same day …

Plexus (PLXS) Is Up 15.1% After Record Q3 Sales And Higher Q4 Guidance Has The Bull Case Changed?

Plexus (PLXS) recently reported record Q3 2026 revenue of US$1.30 billion and provided strong Q4 guidance, sending its stock up 15.1%. The company's focus on complex electronics, combined with ongoing share repurchases, supports its investment narrative, though investor awareness of potential demand setbacks due …

Enerflex earnings ahead as analysts cut EPS estimates sharply

Enerflex Ltd. is expected to report second-quarter earnings, with analysts significantly lowering profit expectations, forecasting a 38% year-over-year decrease in EPS to $0.30, despite a slight sequential revenue increase. The company's ability to maintain profitability in higher-value service segments and leverage growing demand for …

Enerflex Ltd. $EFXT Shares Acquired by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company significantly increased its stake in Enerflex Ltd. (NYSE:EFXT) by 141.8% in the first quarter, now owning 423,361 shares valued at $8.85 million. Despite institutional investors holding 46.47% of the company, Enerflex reported mixed financial results with an earnings beat …

ARE Dividend Yield Pushes Past 6%

Looking at the universe of stocks we cover at Dividend Channel, in trading on Wednesday, shares of Alexandria Real Estate Equities Inc (Symbol: ARE) were yielding above the 6% mark based on its quarterly dividend (annualized to $2.88), with the stock changing hands as …

Alexandria Stands to Lose Nearly $200M on Kips Bay Project

Alexandria Real Estate Equities is facing a potential loss of $183 million in preconstruction costs for the third building of its Kips Bay life sciences campus due to an ongoing dispute with New York City. The conflict, which began over two years ago, involves …

Lexeo's LX2020 Secures FDA RMAT Tag For PKP2-Associated Arrhythmogenic Cardiomyopathy

(RTTNews) - Lexeo Therapeutics (LXEO) on Wednesday announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to LX2020 for the treatment of PKP2-associated arrhythmogenic cardiomyopathy (PKP2-ACM). PKP2-associated arrhythmogenic cardiomyopathy is a rare inherited heart disease caused …

Is Flex (FLEX) Stock Outpacing Its Computer and Technology Peers This Year?

Investors interested in Computer and Technology stocks should always be looking to find the best-performing companies in the group. Is Flex (FLEX) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out. Flex is one …

Rolex Rings Posts Solid Q1 FY27 Profits on Stable Revenue

Plexus Q3 Beat, Strong Outlook Clouded by Free Cash Flow Concerns

Plexus Corp. reported strong fiscal third-quarter results, beating revenue and earnings estimates, driven by new program ramps and industrial demand. The company provided an optimistic outlook for fiscal 2026 and 2027, projecting continued revenue growth and margin expansion. However, increased working capital requirements for …

Lexeo wins FDA RMAT designation for LX2020 in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics has received FDA Regenerative Medicine Advanced Therapy (RMAT) designation for its gene therapy LX2020, intended for PKP2-associated arrhythmogenic cardiomyopathy. This designation was granted based on positive interim data from the ongoing Phase I/II HEROIC-PKP2 trial. LX2020 previously received FDA Orphan Drug and …

Goldman Sachs Maintains Alexandria Real Estate Equities Inc(ARE.US) With Hold Rating, Maintains Target Price $52

Goldman Sachs has reiterated its Hold rating on Alexandria Real Estate Equities Inc (ARE.US), keeping the target price at $52. This indicates that the firm does not foresee significant upward or downward movement for the stock in the near term. Investors may interpret this …

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Rating Lowered by Zacks Research

Renaissance Technologies LLC Makes New $7.07 Million Investment in Plexus Corp. $PLXS

Renaissance Technologies LLC has invested $7.07 million in Plexus Corp. by acquiring 34,893 shares. This makes Renaissance Technologies a 0.13% stakeholder in the company, which is 94.45% owned by institutional investors. Plexus Corp. has a "Moderate Buy" consensus rating from analysts, a $273 average …